Brief: ImmuCell Announces Unaudited Financial Results For The Quarter Ended Sept 30, 2022
Nov 21 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE
QUARTER
ENDED SEPTEMBER 30, 2022
* IMMUCELL CORP - LOSS PER SHARE $0.08 DURING QUARTER ENDED
SEPTEMBER 30, 2022
* IMMUCELL CORP - QTRLY TOTAL SALES $4.80 MILLION, DOWN 7%
Source text for Eikon: ID:nGNX7Rylw9
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year